triptolide has been researched along with Myelodysplastic Syndromes in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cen, JN; Gao, HQ; Hua, HY; Sun, AN; Wu, LL | 1 |
Deng, J; Jin, J | 1 |
2 other study(ies) available for triptolide and Myelodysplastic Syndromes
Article | Year |
---|---|
Arsenic trioxide and triptolide synergistically induce apoptosis in the SKM‑1 human myelodysplastic syndrome cell line.
Topics: Apoptosis; Arsenic Trioxide; Arsenicals; bcl-2-Associated X Protein; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cell Survival; Diterpenes; Drug Synergism; Epoxy Compounds; Gene Expression Regulation, Neoplastic; Humans; Myelodysplastic Syndromes; Oxides; Phenanthrenes; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species | 2016 |
[Study of triptolide-induced apoptosis in MUTZ-1 cells and its allied mechanism].
Topics: Antineoplastic Agents, Alkylating; Apoptosis; Baculoviral IAP Repeat-Containing 3 Protein; Blotting, Western; Caspase 3; Cell Line; Diterpenes; Epoxy Compounds; Flow Cytometry; Gene Expression; Humans; Inhibitor of Apoptosis Proteins; Myelodysplastic Syndromes; Phenanthrenes; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Ubiquitin-Protein Ligases | 2005 |